StockStory.org on MSN
TFX Q1 deep dive: Portfolio reshaping drives growth, margin pressures persist
Medical technology company Teleflex (NYSE:TFX) reported Q1 CY2026 results , with sales up 32.3% year on year to $548.3 ...
The partnership will help surgeons perform robotic surgeries by taking advantage of a differentiated technology such as Weck by Teleflex. On the other hand, the partnership will help Teleflex expand ...
Oct 31 (Reuters) - Teleflex (TFX.N), opens new tab shares dropped more than 16% on Thursday, after the surgical instrument maker cut its annual revenue forecast to reflect canceled surgeries in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results